Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
ARTIS Ventures Leads $18 Million Series A Financing for Conceivable Life Sciences to Advance AI-Powered Automated IVF Lab
Jan 14, 2025•over 1 year ago
Contract Type
partnership
Description
Conceivable Life Sciences has closed an $18 million Series A financing led by ARTIS Ventures, with the participation of new investors, raising over $39 million to date. The funds will support the ongoing commercial pilot program in Mexico City and preparations for a U.S. launch in early 2026. The company is revolutionizing the future of fertility care by synthesizing AI and robotics to automate the intricate steps required for IVF procedures.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months